Wird geladen...
Simultaneous determination of newly developed antiviral agents in pharmaceutical formulations by HPLC-DAD
BACKGROUND: Ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak(®)) are the newest medicines approved for use in the treatment of hepatitis C virus (HCV) and are available in tablet form as an oral combination. Specifically, these agents are indicated in the treatment of HCV in patients with ge...
Gespeichert in:
| Veröffentlicht in: | Chem Cent J |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer International Publishing
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214962/ https://ncbi.nlm.nih.gov/pubmed/28101128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13065-016-0232-6 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|